<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We have analysed the quantitative expression of surface CD69 antigen on human mast cells (MC), from both <z:mpath ids='MPATH_458'>normal</z:mpath> and pathological bone marrow (BM) samples, using flow cytometry </plain></SENT>
<SENT sid="1" pm="."><plain>Our major aim was to analyse whether CD69 is constitutively expressed by <z:mpath ids='MPATH_458'>normal</z:mpath> BMMC and to explore the possible differences between CD69 expression by BMMC from <z:mpath ids='MPATH_458'>normal</z:mpath> controls and patients suffering from different pathological conditions </plain></SENT>
<SENT sid="2" pm="."><plain>The constitutive expression of surface CD69 was clearly demonstrated in BMMC; however, <z:e sem="disease" ids="C0221013" disease_type="Disease or Syndrome" abbrv="">systemic mast cell disease</z:e> (SMCD) patients showed significantly higher levels of surface CD69 expression than healthy controls (P &lt; 0.001), <z:hpo ids='HP_0011010'>chronic</z:hpo> lymphocytic <z:mpath ids='MPATH_336'>leukaemia</z:mpath> (P = 0.001), <z:e sem="disease" ids="C0278494" disease_type="Neoplastic Process" abbrv="MGUS">monoclonal gammopathy of unknown significance</z:e> (P &lt; 0.001), <z:hpo ids='HP_0006775'>multiple myeloma</z:hpo> (P &lt; 0.001) patients, and <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (P = 0.002) </plain></SENT>
<SENT sid="3" pm="."><plain>Furthermore, almost no overlap between the levels of CD69 expression on BMMC was observed between SMCD cases and the remaining groups of individuals except for the paediatric <z:hpo ids='HP_0100495'>mastocytosis</z:hpo> group (P &gt; 0.05) </plain></SENT>
<SENT sid="4" pm="."><plain>From the other groups of patients, <z:e sem="disease" ids="C0278494" disease_type="Neoplastic Process" abbrv="MGUS">monoclonal gammopathy of unknown significance</z:e> (P = 0.04), <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (P = 0.03) and paediatric <z:hpo ids='HP_0100495'>mastocytosis</z:hpo> (P = 0.003) cases showed a significantly higher expression of surface CD69 as compared to <z:mpath ids='MPATH_458'>normal</z:mpath> subjects </plain></SENT>
<SENT sid="5" pm="."><plain>In summary, our findings show that the CD69 antigen is overexpressed in SMCD patients </plain></SENT>
</text></document>